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Abstract
OBJECTIVES: The aim of the study was to carry out a survey in patients with fibromyalgia (FM), to
examine their general health status and work incapacity (disability-pension status), and their views on
the effectiveness of therapy received, over a two-year observation period. METHODS: 48 patients
diagnosed with FM, according to the American College of Rheumatology (ACR) criteria, took part in
the study. At baseline, and on average two years later, the patients underwent clinical investigation
(dolorimetry, laboratory diagnostics, medical history taking) and completed the Fibromyalgia
questionnaire (Dettmer and Chrostek 1). RESULTS: 27/48 (56%) patients participated in the two-year
follow-up. In general, the patients showed no improvement in their symptoms over the observation
period, regardless of the type of therapy they had received. General satisfaction with quality of life
improved, as did satisfaction regarding health status and the family situation, although the degree of
pain experienced remain unchanged. In comparison with the initial examination, there was no change in
either work-capacity or disability-pension status. CONCLUSIONS: The FM patients showed no
improvement in pain, despite the many various treatments received over the two-year period. The
increase in general satisfaction over the observation period was believed to be the result of patient
instruction and education about the disease. To what extent a population of patients with FM would
show similar outcomes if they did not receive any instruction/education about their disorder, cannot be
ascertained from the present study; and, indeed, the undertaking of a study to investigate this would be
ethically questionable. As present, no conclusions can be made regarding the influence of therapy on the
primary and secondary costs associated with FM.
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Abstract
Objectives: The aim of the study was to carry out a survey in patients with fibromyalgia (FM), to
examine their general health status and work incapacity (disability-pension status), and their views
on the effectiveness of therapy received, over a two-year observation period.
Methods: 48 patients diagnosed with FM, according to the American College of Rheumatology
(ACR) criteria, took part in the study. At baseline, and on average two years later, the patients
underwent clinical investigation (dolorimetry, laboratory diagnostics, medical history taking) and
completed the Fibromyalgia questionnaire (Dettmer and Chrostek [1]).
Results: 27/48 (56%) patients participated in the two-year follow-up. In general, the patients
showed no improvement in their symptoms over the observation period, regardless of the type of
therapy they had received. General satisfaction with quality of life improved, as did satisfaction
regarding health status and the family situation, although the degree of pain experienced remain
unchanged. In comparison with the initial examination, there was no change in either work-capacity
or disability-pension status.
Conclusions: The FM patients showed no improvement in pain, despite the many various
treatments received over the two-year period. The increase in general satisfaction over the
observation period was believed to be the result of patient instruction and education about the
disease. To what extent a population of patients with FM would show similar outcomes if they did
not receive any instruction/education about their disorder, cannot be ascertained from the present
study; and, indeed, the undertaking of a study to investigate this would be ethically questionable.
As present, no conclusions can be made regarding the influence of therapy on the primary and
secondary costs associated with FM.
Introduction
Fibromyalgia (FM), or FM syndrome, is a non-articular
rheumatic disease with a prevalence of 1–3% [2–4]. The
clinical symptoms include distinctive pain throughout the
whole body. Females are more often affected than males
[5]. The mean age at disease onset is approximately 42
years and the mean disease duration, 10–12 years [5]. The
socio-economic problems associated with the chronic
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society alike. The persistence of the symptoms makes the
prognosis in relation to work capacity extremely difficult.
Patients often retire prematurely from the work force –
usually after long periods of absence from work – such
that, over and above the costs associated with treatment
itself (direct costs), considerable indirect costs arise in
connection with disability pensions and income loss
(indirect costs). The latter are difficult to quantify with
any certainty, as official records are often inaccessible, but
they are estimated to amount to some 15–20% of the total
costs in the field of Rheumatology [6]. This represents
1.2% of the gross national product of Switzerland [7] and
is comparable to the expenditure in other European coun-
tries [8]. FM is clearly a problem that deserves more inten-
sive scientific investigation, in relation to both its
epidemiology and its socio-medical and economic
consequences.
The aim of the present study was to examine the course of
the disease, with respect to vegetative and functional
symptoms and treatments received over a two-year obser-
vation period, in 48 patients with FM.
It was hoped that the findings might assist in identifying
potentially successful treatment strategies that would be
worthy of closer investigation in further studies, and in
providing more information on the likelihood of work-
retirement due to persistent symptoms.
Methods
48 patients (45 women and 3 men) diagnosed with FM
according to the ACR classification criteria [9] were
included in the study. Their mean (± SEM) age, weight
and height were 47.6 ± 1.9 years, 76.6 ± 2.0 kg, and 165 ±
0.01 cm, respectively. The mean duration of the disease
(time since appearance of the first symptoms) was 7.2 ±
0.9 years. The demographic data for the study group is
summarized in Table 1.
Upon entry to the study (T0) and on average two years
later (T1) (2.0 ± 0.3 y), laboratory diagnostics and a
detailed rheumatological examination, including dolor-
imetry, were carried out. The patients completed the
Fibromyalgia questionnaire of Dettmer and Chrostek [1],
which enquired about marital status, educational
background, general state of health, functional and vege-
tative symptoms, anamnesis regarding pain of the loco-
motor system, pain behavior, functional disturbances in
relation to the time of day and stress and activity. Factors
that are intrinsically associated with the disease, such as
medication, satisfaction with life (visual analogue scale
from 0–10; 0 = very unsatisfied, 10 = very satisfied), gen-
eral well-being (0 = very bad, 10 = very good) and the
effectiveness of therapeutic measures, were also enquired
about. Pain intensity in 24 body parts was rated from 0 =
no pain to 4 = very severe pain; these scores were summed
to give a total pain score for each patient, between 0 and
96 points.
At time-point T1 (2 years later), the patients completed
this same questionnaire again, together with a further
questionnaire enquiring about treatments, clinical exami-
nations, methods of treatment, inpatient treatment,
planned treatment strategies, and the course of the symp-
toms in the intervening period. Questions about work
incapacity and disability payments were included.
Results
Dolorimetry, pain and functional/vegetative symptoms at 
time point T0
The dolorimetric examination revealed a mean (± SEM)
number of positive tender points per patient of 16.6 ± 0.5.
The mean pain threshold for these was 1.4 ± 0.04 kp. The
pain score was 53.3 ± 2.8. Table 2 shows the frequency of
functional and vegetative symptoms. The difference of
"moderate" and "high" has pathological meaning.
Table 1: Demographic composition of the patient collective
Family Status
Single 4.2%
Single living with partner 2.1%
Married living with partner 68.8%
Married living apart 4.2 %
Divorced 4.2%
Widowed 2.1%
No details 14.4%
Education
Primary school 39.6%
Secondary school 25%
Technical school 6.3%
High school graduation 6.3%
Other 10.4%
No details 18.7%
Professional activities
Working 20.8%
0 – 1 no longer employed 6.3%
1 – 5 no longer employed 25%
>10 no longer employed 16.7%
No details 31.2%
Severity of physical 
activities of those 
still employed
Multiple layered and heavy 18.8%
Multiple layered/middle heavy 20.8%
Multiple layered /light 6.3%
Shift work/Accord 2.1%
Part time 12.5%
Missing details 39.5%Page 2 of 6
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severe form in more than 50% of the patients: distur-
bances in getting to sleep and insomnia, sensory distur-
bances of the upper extremities, heat complaints, cold
acres, headaches, orthostatic reactions, morning stiffness,
fatigue, hyperhydrosis, the feeling of swollenness in the
extremities, and diminished overall capabilities (83.3%!).
The results of the visual analogue scale ratings from 0–10
provide more specific information about the patients'
pain-induced functional limitations (Table 3):
Pattern of pain at time point T0
In their pain history 4.2% of the patients reported a dra-
matic onset of pain over a short period of time, 16.7%
reported a slow progression of pain over a longer period
of time, 54.2% reported flare-ups of pain over and above
an ongoing pain problem and 10.4% reported flare-ups
with pain-free intervals. 14.5% of the patients gave no
information about their pain pattern.
Factors influencing the pain and activity factors at T0
77.1% of the patients declared no diurnal changes in their
pain, though a dependency on other factors (physical,
psychological, weather) was reported (68.6% of the
patients). 12.5% of the patients carried out less than an
hour of physical activity per day, 12.5% 1–2 hours per day
and 10.4% more than 2 hours a day. 52.1% of the patients
carried out no sport at all.
41.7% of the patients answered the question about the
possible cause of their symptoms with "don't know".
14.6% suspected that occupational factors might be
responsible, 4.2% family burdens, 4.2% previous opera-
tive procedures, and 2.1% previous infection. 33.3% of
the patients saw no connection between the course of the
disease and any of these possible burdens (occupational
burdens infections, and operations).
At time point T0, 68.8% of the patients were being treated
with medication for pain and rheumatic complaints.
45.8% of the whole group felt that the medication did not
Table 2: Frequency of occurrence of functional and vegetative symptoms in percent of the degree of pronouncement (ordered 
alphabetically). 42 patients answered the questions.
Symptom None Slight Moderate Strong
Allergy 50.0 8.3 14.6 14.6
Breathlessness 41.7 14.6 27.1 4.2
Stomach complaints 41.7 14.6 20.8 10.4
Complaints urinating 60.4 16.7 4.2 6.3
Diarrhoea 68.8 6.3 10.4 2.1
Trouble sleeping through 12.5 10.4 27.1 37.5
Trouble going to sleep 12.5 12.5 31.3 31.3
Disturbances of the senses of the upper extremity 22.9 12.5 35.4 16.7
Disturbances of the senses of the lower extremity 18.8 20.8 31.3 16.7
Heart problems 25.0 12.5 33.3 16.7
Cold hands or feet 14.6 14.6 33.3 25.0
Lump in the throat feeling 35.4 12.5 25.0 14.6
Headaches 12.5 18.8 16.7 39.6
Circulatory disturbances 14.6 16.7 35.4 20.8
Morning Stiffness 12.5 2.1 39.6 33.3
Fatigue 12.5 10.4 39.6 25.0
Tendency to sweat 20.8 14.6 27.1 25.0
Menstruation pain 62.5 4.2 6.3 14.6
Swallowing problems 56.3 12.5 16.7 2.1
Swelling of the upper extremity 31.3 6.3 37.5 12.5
Swelling of the lower extremity 27.1 12.5 29.2 18.8
Indigestion 54.2 8.3 14.6 10.4
Dry mouth 29.2 14.6 22.9 20.8
Irregular menstruation 77.1 2.1 4.2 4.2
Reduced capability 2.1 2.1 33.3 50.0
Constipation 60.4 10.4 10.4 6.3
Feeling full 33.3 6.3 25.0 22.9
Trembling hands 43.8 14.6 25.0 4.2
The differences of 100 % correspond to the missing details.Page 3 of 6
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pain. Other therapy forms (especially active and passive
physical modalities) had been tried by 85.4% of the
patients without satisfactory long-term effects. 29.2% of
the patients had previously been treated on an inpatient
basis in connection with their diagnosis of FM (during
investigation of their symptoms). 60.4% of the patients
had previously undergone surgery for disorders of the
locomotor system (and also of the gynecological and
abdominal systems), without any satisfactory effect.
Patients' history between time points T0 and T1
Change in the social environment
31.9% of the patients reported no change in their social
environment between T0 and T1. 8.5% reported changes
in their workplace, and 6.4% changes in their leisure
activities.
Planning of further treatment strategies
There were no further treatment measures planned by the
treating therapist for 25.5% of the patients. 55.3% of the
patients were being treated pragmatically, e.g. symptom-
oriented, in various ways, and 2.1% were being treated
with acupuncture. 53.2% of the patients had consulted
more than one doctor. Only 4.3% had been treated by
their family doctor. 44.7% of the patients reported that
they had suffered severely from insomnia. 51.1% of the
patients had a daily schedule with regular times for getting
up, relaxing, eating, leisure activities and sleeping. 44.7%
of the patients declared that pain of the locomotor system
was their main complaint.
Pension application and retirement
By time-point T1, 19.1% (n = 9) of the patients had
applied for a disability pension, which was one patient
more than at time-point T0.
In-patient treatment
27.7% of the patients had had no intermediary inpatient
treatment for their FM symptoms in the observation
period; 23.4 % had had less than 2 inpatient treatments
and 6.4% more than 2 inpatient treatments.
Further examinations
36.2% of the patients had undergone further diagnostic
investigations over the observation period; 10.6% had
had an X-ray examination. Only 6.4% had undergone fur-
ther diagnostic examinations due to their existing
symptoms.
Examination at time point T1 (2 Years ± 3 Months)
27 patients (56%) took part in the examination at T1. The
significant changes observed between T0 and T1 are
shown in Table 4. No changes were recorded in the varia-
bles: disturbances getting to sleep, insomnia, tender
points, blood sedimentation rate, influence of medica-
tion, difficulties passing water, work capacity, drive,
morning stiffness, influence of therapy measures (espe-
cially medication), circulation disturbances, headaches,
lump in the throat feeling, heart complaints, body weight,
sensory disturbances of the lower extremities, sensory dis-
turbances of the upper extremities, leisure time, financial
status, marital status, sense of swollenness of the upper
extremities, pain, influence of other factors on pain, swal-
lowing problems, pain pattern, menstruation pain,
depression, tendency to sweat, and diurnal changes in
symptoms.
Discussion
Between baseline and follow-up, significant improve-
ments were recorded in all the vegetative symptoms, with
the exception of "dry mouth" (Table 4). The patients at
time point T1 who had an unchanged number of tender
Table 3: Visual Analogue Scale from 0 to 10. Both extremes are 
noted under the heading.
Medium ± SEM
General state of health assessment
(very bad – very good) 2.8 ± 0.3
Assessment of lack of motivation
(very frequent – more or less never) 4.2 ± 0.4
Contentment with the work situation
(very dissatisfied – very satisfied) 4.1 ± 0.6
Obstruction through state of health
(very much – absolutely not) 1.9 ± 0.2
Worry because of state of health
(very much – absolutely not) 2.0 ± 0.3
Contentment with relationship with friends etc.
(very dissatisfied – very satisfied) 7.1 ± 0.4
Contentment with family situation
(very dissatisfied – very satisfied) 7.5 ± 0.4
Contentment with financial situation
(very dissatisfied – very satisfied) 5.2 ± 0.4
Contentment with leisure time
(very dissatisfied – very satisfied) 6.7 ± 0.4
General contentment
(very dissatisfied – very satisfied) 4.3 ± 0.4
Worry about health
(very frequent – more or less never) 1.6 ± 0.3
Depression
(very frequent – more or less never) 4.3 ± 0.5
Strength of feeling of pain
(Very strong – hardly at all) 2.0 ± 0.2
Restlessness and tenseness
(very frequent – more or less never) 2.5 ± 0.4
Frequency of full exhaustion
(very frequent – more or less never) 2.3 ± 0.4
Contentment with living situation
(very dissatisfied – very satisfied) 7.4 ± 0.4Page 4 of 6
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score. None of the therapeutic measures that had been
implemented (medicinal, physiotherapy, psychotherapy)
had resulted in any improvement. Despite this, the self-
rated general state of health showed a significant improve-
ment (p = 0.001).
Generally, it may be concluded that the current therapies
implemented for the treatment of FM appear to be ineffec-
tive, and this clearly results in a frustrating situation for
both the patient and therapist alike. There is currently no
clear understanding of the pathogenesis of FM and, as
such, poly-pragmatic therapeutic recommendations [10]
remain the only recommended treatment option. Over
the two-year period of observation, our patients showed
no fundamental changes in the parameters investigated.
Thus, instruction and information about the disease
might be the only relevant tools to stabilize the patient's
general satisfaction with the situation, even if the pain
experienced does not change. These "small" successes
should be seen as sufficient grounds for implementing
interdisciplinary approach in FM, without undertaking
extensive, unfounded diagnostic and/or therapeutic
interventions. The reported increase in dry-mouth is pri-
marily attributable to therapy with anti-depressive medi-
cation (in particular tricyclic anti-depressants). Over the
study duration, there were no significant changes in the
patients' work capacity or disability-pension status. To
what extent the patients would have shown a different
course of disease without any therapeutic intervention, or
care from healthcare professionals, cannot be ascertained
from the present study; and, indeed, such studies are dif-
ficult to implement, for ethical reasons.
In conclusion, independent of the applied therapeutic
management of the disease, there was neither a clinical
relevant benefit nor a worsening of symptoms in our
investigated group of patients.
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